Insider Transactions in Q1 2023 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
5,000
-12.54%
|
$250,000
$50.0 P/Share
|
|
Mar 31
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.14%
|
$60,000
$12.89 P/Share
|
|
Mar 31
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
4,000
-10.42%
|
$200,000
$50.0 P/Share
|
|
Mar 30
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
4,903
-5.54%
|
$240,247
$49.6 P/Share
|
|
Mar 23
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
6,703
-22.58%
|
$315,041
$47.97 P/Share
|
|
Mar 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-11.64%
|
$548,537
$47.6 P/Share
|
|
Mar 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.14%
|
$89,712
$14.7 P/Share
|
|
Mar 02
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
30,000
-11.72%
|
$1,380,000
$46.66 P/Share
|
|
Mar 01
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
75,610
-22.8%
|
$3,478,060
$46.64 P/Share
|
|
Mar 01
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,610
+4.59%
|
$684,150
$15.55 P/Share
|
|
Mar 01
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
5,000
-12.54%
|
$230,000
$46.66 P/Share
|
|
Mar 01
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.14%
|
$60,000
$12.89 P/Share
|
|
Feb 22
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
3,340
-3.64%
|
$153,640
$46.1 P/Share
|
|
Feb 21
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,462
-0.4%
|
$343,252
$46.23 P/Share
|
|
Feb 21
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,825
+0.9%
|
-
|
|
Feb 21
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
2,313
-2.46%
|
$106,398
$46.32 P/Share
|
|
Feb 21
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,279
-1.34%
|
$58,834
$46.23 P/Share
|
|
Feb 21
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,804
+2.86%
|
-
|
|
Feb 21
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.72%
|
$11,592
$46.23 P/Share
|
|
Feb 21
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
623
+1.74%
|
-
|
|
Feb 21
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-1.51%
|
$45,678
$46.23 P/Share
|
|
Feb 21
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+2.53%
|
-
|
|
Feb 21
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,624
-0.56%
|
$74,704
$46.23 P/Share
|
|
Feb 21
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,661
+1.26%
|
-
|
|
Feb 21
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
761
-2.5%
|
$35,006
$46.23 P/Share
|
|
Feb 21
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,714
+5.33%
|
-
|
|
Feb 21
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
691
-0.73%
|
$31,786
$46.23 P/Share
|
|
Feb 21
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,558
+1.62%
|
-
|
|
Feb 21
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
229
-0.55%
|
$10,534
$46.23 P/Share
|
|
Feb 21
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
779
+1.83%
|
-
|
|
Feb 21
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,923
-0.87%
|
$88,458
$46.23 P/Share
|
|
Feb 21
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+1.72%
|
-
|
|
Feb 21
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
498
-1.28%
|
$22,908
$46.23 P/Share
|
|
Feb 21
2023
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,091
+2.73%
|
-
|
|
Feb 18
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-1.41%
|
$24,886
$46.54 P/Share
|
|
Feb 18
2023
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,186
+3.0%
|
-
|
|
Feb 18
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-0.73%
|
$11,684
$46.54 P/Share
|
|
Feb 18
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+1.8%
|
-
|
|
Feb 18
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,159
-1.77%
|
$53,314
$46.54 P/Share
|
|
Feb 18
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,001
+2.97%
|
-
|
|
Feb 18
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.53%
|
$10,028
$46.54 P/Share
|
|
Feb 18
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
741
+1.76%
|
-
|
|
Feb 18
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,644
-0.58%
|
$75,624
$46.54 P/Share
|
|
Feb 18
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.28%
|
-
|
|
Feb 18
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-0.88%
|
$37,812
$46.54 P/Share
|
|
Feb 18
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+1.94%
|
-
|
|
Feb 18
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-3.53%
|
$48,392
$46.54 P/Share
|
|
Feb 18
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,372
+7.38%
|
-
|
|
Feb 18
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,829
-0.83%
|
$84,134
$46.54 P/Share
|
|
Feb 18
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.66%
|
-
|